{"schema_version":"secwatch.filing_event.v1","accession":"0001570562-25-000006","form_type":"8-K","ticker":"EOLS","cik":"0001570562","company_name":"Evolus, Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.033416+00:00","generated_at":"2026-05-27T22:08:38.083406+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evolus posts record FY2024 revenue $266.3M (+32%); guides 2025 $345-355M; FDA for HA gels within 90 days","bullets":["Preliminary Q4 2024 net revenue $79.0M (+30% YoY); FY2024 net revenue $266.3M (+32% YoY) at top of guidance ($260-266M).","Expects FDA approval within 90 days for Evolysse Form and Smooth HA gels; US launch planned Q2 2025, a quarter ahead of prior timeline.","2025 revenue guidance $345-355M (30-33% growth); non-GAAP operating expenses $230-240M; positive non-GAAP operating income expected for full-year 2025.","Cash and equivalents $87M as of Dec 31, 2024, up from $85M on Sep 30; >15,300 accounts purchasing Jeuveau since launch.","Evolus Rewards enrollment grew over 40% to ~1.1M; Q4 redemptions record ~220,000, with ~60% from repeat treatments."],"urls":{"canonical":"https://secwatch.observer/filing/0001570562-25-000006","json":"https://secwatch.observer/filing/0001570562-25-000006.json","markdown":"https://secwatch.observer/filing/0001570562-25-000006.md","text":"https://secwatch.observer/filing/0001570562-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000006/0001570562-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000006/eols-20250121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T22:08:38.083406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}